{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:02:24Z","timestamp":1793696544291,"version":"4.5.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bmcl.2022.128824","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T12:05:07Z","timestamp":1653653107000},"page":"128824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent"],"prefix":"10.1016","volume":"71","author":[{"given":"Zhigang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G","family":"Franzblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4927-3328","authenticated-orcid":false,"given":"Charles Z.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128824_b0005","unstructured":"NIH Review (2021), Barry R Bloom, Rifat Atun, et al., Tuberculosis, (online), https:\/\/pubmed.ncbi.nlm.nih.gov\/30212088\/;."},{"key":"10.1016\/j.bmcl.2022.128824_b0010","unstructured":"WHO (2021), Tuberculosis, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis."},{"key":"10.1016\/j.bmcl.2022.128824_b0015","unstructured":"WHO (2021) Global Tuberculosis Report https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-tuberculosis\/tb-report-2021\/factsheet-global-tb-report-2021.pdf?sfvrsn=86011b1e_5&download=true."},{"key":"10.1016\/j.bmcl.2022.128824_b0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"Diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Koen","year":"2005","journal-title":"Science"},{"issue":"5707","key":"10.1016\/j.bmcl.2022.128824_b0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.1108379","article-title":"Microbiology TB a new target, a new drug","volume":"307","author":"Cole","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128824_b0030","unstructured":"https:\/\/www.who.int\/tb\/publications\/2018\/WHO_RapidCommunicationMDRTB.pdf."},{"key":"10.1016\/j.bmcl.2022.128824_b0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment\u20132017,et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bmcl.2022.128824_b0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cmi.2020.06.004","article-title":"Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study","volume":"27","author":"Gao","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bmcl.2022.128824_b0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/13993003.00724-2015","article-title":"TMC207-C209 Study Group. 2016. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis","volume":"47","author":"Pym","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bmcl.2022.128824_b0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tube.2019.06.005","article-title":"A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity","volume":"117","author":"Patel","year":"2019","journal-title":"Tuberculosis (Edinb)"},{"issue":"4","key":"10.1016\/j.bmcl.2022.128824_b0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem Res Toxicol"},{"issue":"11","key":"10.1016\/j.bmcl.2022.128824_h0060","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.4155\/fmc.11.79","article-title":"Diarylquinolines, synthesis pathways and quantitative structure\u2013activity relationship studies leading to the discovery of TMC207","volume":"3","author":"Guillemont","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2022.128824_h0065","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1039\/D1MD00063B","volume":"12","author":"Barbaro","year":"2021","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2022.128824_b0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4939-2450-9_17","article-title":"Microplate Alamar Blue Assay (MABA) and Low Oxygen Recovery Assay (LORA) for Mycobacterium tuberculosis","volume":"1285","author":"Cho","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2022.128824_b0070","doi-asserted-by":"crossref","unstructured":"Yao R, Wang B, Lu Y, et al. Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis Microbiol Spectr. 2022;10(1):e0247721. 10.1128\/spectrum.02477-21.","DOI":"10.1128\/spectrum.02477-21"},{"key":"10.1016\/j.bmcl.2022.128824_b0075","doi-asserted-by":"crossref","unstructured":"Cho S, Yang TJ, Franzblau SG, et al. In vitro and in vivo activities of the nitroimidazole TBA354 against Mycobacterium tuberculosis. Antimicrob Agents Chemother., 2015, 59, 136 \u2013144. DIO:10.1128\/AAC.03823-14.","DOI":"10.1128\/AAC.03823-14"},{"key":"10.1016\/j.bmcl.2022.128824_b0085","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/psp4.12147","article-title":"Population pharmacokinetics of bedaquiline and metabolite M2 in patients with drug-resistant tuberculosis: the effect of time-varying weight and albumin","volume":"12","author":"Svensson","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.bmcl.2022.128824_b0090","unstructured":"Evaluation of early bactericidal activity and safety in pulmonary tuberculosis with WX-081. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04608955?term=WX-081&draw=2&rank=1."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22003006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:45:13Z","timestamp":1760773513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22003006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":18,"alternative-id":["S0960894X22003006"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128824","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128824"}}